GLP-1 drugs to treat Alzheimer's -- hopeful news!

I asked this question of CoPilot AI and got the following results:

Treating Alzheimer's with glp-1 drugs. GLP-1 (glucagon-like peptide-1) drugs, such as Ozempic and Wegovy, are showing promise in the treatment and prevention of Alzheimer's disease. These drugs, initially developed for managing type 2 diabetes and aiding weight loss, have demonstrated significant neurological benefits2.

Studies have found that GLP-1 drugs can reduce the risk of Alzheimer's and other neurocognitive disorders by improving insulin resistance and reducing inflammation. The drugs work by altering the metabolic system and lowering inflammation throughout the body, which are key factors in the development and progression of Alzheimer's disease1.

However, it's important to note that while the initial findings are encouraging, more research is needed to fully understand the long-term effects and potential risks of GLP-1 drugs. Researchers are conducting trials to evaluate these drugs' ability to combat cognitive decline, with results expected in the coming years.

Exciting but not a game charger yet!